EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeted next-generation sequencing for respiratory infections in patients with haematological malignancies

Jiayu Huang, Su Li, Chuanhe Jiang, Luxiang Wang, Zengkai Pan, Zilu Zhang, Jun Zhu, Wei Chen, Xiaoxia Hu

Frontiers in Cellular and Infection Microbiology · 19.11.2025 · 15

DOI: 10.3389/fcimb.2025.1678858 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 19.11.2025. Verfasst von Jiayu Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine, Shanghai Rui Jin Hos…. Hauptthemen laut MEDLINE: Hematologic Neoplasms, Respiratory Tract Infections, High-Throughput Nucleotide Sequencing. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with haematological malignancies are immunocompromised and prone to respiratory infections, but identification of causative pathogens is challenging. The aim of this study was to analyse the ability of targeted next-generation sequencing (tNGS) to detect pathogens in immunocompromised patients. Methods tNGS and conventional microbiological tests (CMT) were performed on samples from the respiratory tract of 99 patients with suspected respiratory infections. Metagenomic next-generation sequencing (mNGS) was conducted in parallel in 43 patients. Comparative analysis was conducted using the Pearson χ2 test and Fisher’s exact test, as appropriate.

Results

The overall microbial detection rates for tNGS were 100% (23/23) in the upper respiratory tract and 96.1% (99/103) in the lower respiratory tract. Microorganism colonization was detected by tNGS in 80.8% (97/120) of cases. The sensitivity of tNGS was approximately 30% higher than that of CMT (87.7% vs. 52.5%; P < 0.001), but tNGS had a lower specificity (33.3% vs. 83.3%; P = 0.242). tNGS improved the overall treatment success rate by 69.7% (69/99 cases) in CMT true-negative or CMT-partially matched cases. In the paired respiratory tNGS and mNGS cases, tNGS verified 73.3% (11/15) cases of infection, while mNGS only verified 40% ( P = 0.139).

Conclusions

Most immunosuppressed patients are colonized by microorganisms, and require prompt identification of the cause of any infections. tNGS has promising diagnostic potential and offers valuable information for optimizing antibiotic therapy, especially when compared to CMT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematologic NeoplasmsRespiratory Tract InfectionsHigh-Throughput Nucleotide SequencingHumansMiddle AgedFemaleMaleAdultAgedImmunocompromised HostSensitivity and SpecificityMetagenomicsYoung AdultAged, 80 and overAdolescentBacteria

Stichwörter der Autor:innen

conventional microbiological testsdiagnostic efficiencymetagenomic next-generation sequencingtargeted next-generation sequencingtreatment efficacy

Autor:innen und Institutionen

  • State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine, Shanghai Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Chi…
  • Collaborative Innovation Center of Hematology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • GoBroad Medical Institute of Hematology (Shanghai Center), Liquan Hospital, Shanghai, China.
  • Department of Pulmonary and Critical Care Medicine, Shanghai Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Institute of Respiratory Diseases, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Zitieren

APA

Huang, J., Li, S., Jiang, C., Wang, L., Pan, Z., Zhang, Z., Zhu, J., Chen, W., & Hu, X. (2025). Targeted next-generation sequencing for respiratory infections in patients with haematological malignancies. Frontiers in Cellular and Infection Microbiology, 15. https://doi.org/10.3389/fcimb.2025.1678858

Vancouver

Huang J, Li S, Jiang C, Wang L, Pan Z, Zhang Z, et al. Targeted next-generation sequencing for respiratory infections in patients with haematological malignancies. Frontiers in Cellular and Infection Microbiology. 2025;15. doi:10.3389/fcimb.2025.1678858

BibTeX
@article{Huang2025,
  author = {Huang, Jiayu and Li, Su and Jiang, Chuanhe and Wang, Luxiang and Pan, Zengkai and Zhang, Zilu and Zhu, Jun and Chen, Wei and Hu, Xiaoxia},
  title = {Targeted next-generation sequencing for respiratory infections in patients with haematological malignancies},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  volume = {15},
  doi = {10.3389/fcimb.2025.1678858}
}
Kostenlos starten →